PubAg

Main content area

You searched for: Author "Parwiz, Sardar M." Remove constraint Author: "Parwiz, Sardar M." Journal Vaccine Remove constraint Journal: Vaccine
Start Over

Search

Did you mean to type: parviz or parhiz or sarkar or sarwar?

2  Search Results

1 - 2 of 2
Number of results to display per page

Search Results

1. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan

Author:
Parwiz, Sardar M.,   et al.   ; Anwari, Palwasha; Debellut, Frederic; Pecenka, Clint; Clark, Andrew; Groman, Devin; Safi, Najibullah;     Show all 7 Authors
Source:
Vaccine 2018 v.36 no.51 pp. 7769-7774
ISSN:
0264-410X
Subject:
Rotavirus; children; cost effectiveness; diarrhea; disability-adjusted life year; discount rate; hospitals; models; vaccination; vaccines; Afghanistan
Abstract:
... Despite progress made in child survival in the past 20 years, 5.9 million children under five years died in 2015, with 9% of these deaths due to diarrhea. Rotavirus is responsible for more than a third of diarrhea deaths. In 2013, rotavirus was estimated to cause 215,000 deaths among children under five years, including 89,000 in Asia. As of April 2017, 92 countries worldwide have introduced rotav ...
DOI:
10.1016/j.vaccine.2017.10.058

2. Rotavirus is the leading cause of hospitalizations for severe acute gastroenteritis among Afghan children <5 years old

Author:
Parwiz, Sardar M.,   et al.   ; Anwari, Palwasha; Safi, Najibullah; Payne, Daniel C.; Jennings, Mary Carol; Rasikh, Shugufa; Waciqi, Abdul Shakoor;     Show all 7 Authors
Source:
Vaccine 2018 v.36 no.51 pp. 7765-7768
ISSN:
0264-410X
Subject:
Rotavirus; burden of disease; children; diarrhea; enzyme immunoassays; feces; gastroenteritis; gender; hospitals; monitoring; mortality; public health; vaccination; vaccines; vomiting; Afghanistan
Abstract:
... Rotavirus gastroenteritis is estimated to cause approximately five thousand deaths annually among Afghan children under 5 years old. Because laboratory confirmation of rotavirus is not routinely performed in clinical settings, assessing the precise burden of disease attributable to severe rotavirus gastroenteritis typically requires active surveillance efforts. This study describes the current bur ...
DOI:
10.1016/j.vaccine.2017.06.072